Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104601674 | 10460167 | 4 | F | 2014 | 20160906 | 20140917 | 20160907 | EXP | US-PFIZER INC-2014254001 | PFIZER | 64.00 | YR | M | Y | 0.00000 | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104601674 | 10460167 | 1 | PS | LYRICA | PREGABALIN | 1 | 150 MG, 2X/DAY | N | H55704 | 21446 | 150 | MG | CAPSULE, HARD | BID | |||||
| 104601674 | 10460167 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, DAILY (1 PO QD FOR 7 DAYS) | N | 21446 | 75 | MG | CAPSULE, HARD | ||||||
| 104601674 | 10460167 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, 2X/DAY | N | 21446 | 75 | MG | CAPSULE, HARD | BID | |||||
| 104601674 | 10460167 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | UNK UNK, 2X/DAY (50 MG, TAKE 1-2 CAPS) | N | 21446 | CAPSULE, HARD | BID | |||||||
| 104601674 | 10460167 | 5 | C | OXYCODONE | OXYCODONE | 1 | 20 MG, EVERY 4 HRS | 0 | 20 | MG | |||||||||
| 104601674 | 10460167 | 6 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 20 MG, DAILY | 0 | 20 | MG | |||||||||
| 104601674 | 10460167 | 7 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | UNK | 0 | |||||||||||
| 104601674 | 10460167 | 8 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | 30 MG, AS NEEDED (EVERY 4 HS) | 0 | 30 | MG | TABLET | ||||||||
| 104601674 | 10460167 | 9 | C | IMITREX | SUMATRIPTAN SUCCINATE | 1 | Oral | 100 MG, UNK (MAY REPEAT IN 4 HOURS) | 0 | 100 | MG | TABLET | |||||||
| 104601674 | 10460167 | 10 | C | MARIJUANA | CANNABIS SATIVA SUBSP. INDICA TOP | 1 | 1 DF, DAILY | 0 | 1 | DF | TABLET | ||||||||
| 104601674 | 10460167 | 11 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | 1-2 PUFF Q 4-6H | 0 | |||||||||||
| 104601674 | 10460167 | 12 | C | OXYGEN. | OXYGEN | 1 | UNK, 1X/DAY(2% 2.5 LPM AT BED TIME) | 0 | QD | ||||||||||
| 104601674 | 10460167 | 13 | C | SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S)) | HYPROMELLOSE 2910 (4000 MPA.S) | 1 | 0.4-0.3% SOLN | 0 | |||||||||||
| 104601674 | 10460167 | 14 | C | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | UNK, AS NEEDED (1 PR Q6H PRN) | 0 | SUPPOSITORY | ||||||||||
| 104601674 | 10460167 | 15 | C | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | 0 | SUPPOSITORY | |||||||||||
| 104601674 | 10460167 | 16 | C | CARAFATE | SUCRALFATE | 1 | 1 G, 4X/DAY (CRUSH 1 TAB AND ADD 1 TSP OF WATER) | 0 | 1 | G | TABLET | QID | |||||||
| 104601674 | 10460167 | 17 | C | DULERA | FORMOTEROL FUMARATE DIHYDRATEMOMETASONE FUROATE | 1 | 2 PUFF BID | 0 | 2 | DF | BID | ||||||||
| 104601674 | 10460167 | 18 | C | IBUPROFEN. | IBUPROFEN | 1 | 800 MG, 2X/DAY (1 TAB TWICE DAILY) | 0 | 800 | MG | TABLET | BID | |||||||
| 104601674 | 10460167 | 19 | C | IPRATROPIUM BROMIDE. | IPRATROPIUM BROMIDE | 1 | UNK, AS NEEDED (1 VIAL BY NEB Q8H PRN) | 0 | INJECTION | ||||||||||
| 104601674 | 10460167 | 20 | C | IPRATROPIUM BROMIDE. | IPRATROPIUM BROMIDE | 1 | 0 | INJECTION | |||||||||||
| 104601674 | 10460167 | 21 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | 0.5 ML IN HHN EVERY 4 HOURS AS NEEDED | 0 | |||||||||||
| 104601674 | 10460167 | 22 | C | IPRATROPIUM/ALBUTEROL | ALBUTEROLIPRATROPIUM | 1 | ONE VIAL BY NEBULIZER EVERY 6 HOURS AS NEEDED) | 0 | 1 | DF | NEBULISER SOLUTION | ||||||||
| 104601674 | 10460167 | 23 | C | NICORETTE | NICOTINE | 1 | 2 MG, UNK | 0 | 2 | MG | |||||||||
| 104601674 | 10460167 | 24 | C | NAPROSYN | NAPROXEN | 1 | Oral | 250 MG, 2X/DAY | 0 | 250 | MG | TABLET | BID | ||||||
| 104601674 | 10460167 | 25 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Oral | 10 MG, AS NEEDED (EVERY 6 HOURS) | 0 | 10 | MG | TABLET | |||||||
| 104601674 | 10460167 | 26 | C | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, 2X/DAY (1 TAB TWICE DAILY) | 0 | 300 | MG | CAPSULE | BID | |||||||
| 104601674 | 10460167 | 27 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, DAILY (1 TAB PO QD) | 0 | 40 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104601674 | 10460167 | 1 | Back pain |
| 104601674 | 10460167 | 2 | Neck pain |
| 104601674 | 10460167 | 3 | Arthralgia |
| 104601674 | 10460167 | 8 | Pain |
| 104601674 | 10460167 | 9 | Migraine |
| 104601674 | 10460167 | 11 | Dyspnoea |
| 104601674 | 10460167 | 14 | Nausea |
| 104601674 | 10460167 | 15 | Vomiting |
| 104601674 | 10460167 | 18 | Pain |
| 104601674 | 10460167 | 19 | Dyspnoea |
| 104601674 | 10460167 | 20 | Wheezing |
| 104601674 | 10460167 | 22 | Dyspnoea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 104601674 | 10460167 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104601674 | 10460167 | Back pain | |
| 104601674 | 10460167 | Condition aggravated | |
| 104601674 | 10460167 | Gastric haemorrhage | |
| 104601674 | 10460167 | Intentional product use issue | |
| 104601674 | 10460167 | Sensory disturbance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |